Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
14
datasets available to search
ShareScore release 0.9.0
Dataset results
14 results for “Rupatadine”
Green quantitative spectrofluorimetric analysis of rupatadine and montelukast at nanogram scale using direct and synchronous techniques
<p>Two green sensitive spectrofluorimetric methods at nanogram scale were investigated for the determination of rupatadine fumarate (RUP) [method I] and its binary mixture with montelukast (MKT) [method II]. Method I is concerned with measuring the native fluorescence of RUP in presence of 0.10 M H2SO4 and 0.10 % w/v sodium dodecyl sulfate at 455 nm after excitation at 277 nm. The linearity range of the first method was 0.20-2.00 µg/mL with detection and quantitation limits of 11.00 ng/mL and 36.00 ng/mL, respectively. The second method includes the concurrent estimation of RUP and MKT in their co-formulated tablet preparation by applying first derivative synchronous spectrofluorimetric technique. The derivative intensities were measured for the two drugs in aqueous solution containing Mcllvaine's buffer pH 2.60 at fixed wavelength difference (Δλ) of 140 nm. Each drug was estimated at the zero contribution of the other. For RUP, the intensity was measured at 261 nm while MKT was quantitated at 371 nm. The method was linear over the range of 0.10-4.00 µg/mL and 0.20-1.60 µg/mL with limits of detection 4.00 and 5.00 ng/mL and limits of quantitation 13.38 and 15.00 ng/mL for RUP and MKT, respectively. The method was extended to determine the two analytes in laboratory-prepared mixtures and combined tablets. Validation of the two methods was performed according the official recommendations of the International Council of Harmonization (ICH). Statistical interpretation of data revealed that our results were in good agreement with the comparison method. Moreover, the greenness of the methods has been assessed and confirmed by applying three different reported assessment tools.</p>
Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria
ClinicalTrials.gov study NCT00199238. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.
ClinicalTrials.gov study NCT06736340. IPD Sharing: NO. Countries: 2. Publications: 16.
Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants
ClinicalTrials.gov study NCT06708520. IPD Sharing: NO. Countries: 2. Publications: 14.
Green quantitative spectrofluorimetric analysis of rupatadine and montelukast at nanogram scale using direct and synchronous techniques
Open the record for dataset details and reuse information.
Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
ClinicalTrials.gov study NCT02358265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
ClinicalTrials.gov study NCT01605487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance
ClinicalTrials.gov study NCT00162786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on Mastocytosis for Rupatadine Treatment
ClinicalTrials.gov study NCT01481909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers
ClinicalTrials.gov study NCT00199225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparative Study of Rupatadine 10 mg Tablets and Clarinex® 5 mg Tablets Under Fasting Conditions
ClinicalTrials.gov study NCT05356143. IPD Sharing: NO. Countries: 1. Publications: 0.
Rupatadine in Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT07064707. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria
ClinicalTrials.gov study NCT00199251. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
ClinicalTrials.gov study NCT00258141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.